Synthesis and characterization of some heterocyclic schiff bases: Potential anticonvulsant agents

Medicinal Chemistry Research

Volumn 20, Issue 7, 2011, Pages 1091-1101

  Pandey, Shailendra ^a   Srivastava, R S ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

3 Aminomethyl pyridine; Anticonvulsant activity; Heterocyclic schiff bases; Neurotoxicity

Indexed keywords

2 METHOXY 4 [(PYRIDINE 3 YLMETHYLIMINO)METHYL]PHENOL; 3 [1 (PYRIDIN 3 YLMETHYLIMINO)ETHYL]BENZENAMINE; 4 [(PYRIDINE 3 YLMETHYLMINO)METHYL]BENZENE 1,3 DIOL; ANTICONVULSIVE AGENT; N (2 CHLOROBENZYLIDENE)(PYRIDIN 3 YL)METHANAMINE; N (3 PHENYLALLYLIDENE)(PYRIDIN 3 YL)METHANAMINE; N (3,4, DIMETHOXYBENZYLIDENE)(PYRIDIN 3 YL)METHANAMINE; N (DIPHENYLMETHYLENE)(PYRIDIN 3 YL)METHANAMINE; N [(1H INDOL 3 YL)METHYLENE](PYRIDIN 3 YL)METHANAMINE; N CYCLOHEXYLIDENE(PYRIDINE 3 YL)METHANAMINE; PICOLAMINE; PYRIDINE DERIVATIVE; SCHIFF BASE; UNCLASSIFIED DRUG;

ANTICONVULSANT ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; NONHUMAN; PROTECTION; PROTON NUCLEAR MAGNETIC RESONANCE; RAT;

EID: 80054743862     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9441-z     Document Type: Article

References (30)

1. Bekhit AA, Baraka MA (2005) Novel milrinone analogs of pyridine-3-carbonitrile derivatives as promising cardiotonic agents. Eur J Med Chem 40:1405-1413 (Pubitemid 41618285)
2. Bonifàcio MJ, Sheridan RD, Parada A, Cunha RA, Patmore L, Soares-da-Silva P (2001) Interaction of the novel anticonvulsant, BIA 2-093, with voltage-gated sodium channels: Comparison with carbamazepine. Epilepsia 42(5):600-608 (Pubitemid 32453642)
3. Bosque R, Lopez C (1995) Schiff bases derived from aminomethylferrocene and their cyclopalladated derivatives. J Organomet Chem 498:147-154
4. Brodie MJ, Dichter MA (1996) Antiepileptic drugs. N Engl J Med 334:168-175
5. Chiswell B, Crawford JP, O'reilly EJ (1980) Synthesis and complexes of unsymmetrical ligands-part III-quadridentate ligands. Inorg Chim Acta 40:223-228
6. Cory JG, Cory AH, Germana RF, Loricot A, Liut MC, Lint TS, Sartorelli AC (1995) Structure-function relationships for a new series of pyridine-2- carboxaldehyde thiosemicarbazones on ribonucleotide reductase activity and tumor cell growth in culture and in vivo. Adv Enzyme Regul 35:55-68
7. Dunham MS, Miya TA (1957) A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc Sci Edit 46:208-209
8. Ferrarinia PL, Moria C, Badawnehb M, Calderonec V, Grecoc R, Maneraa C, Martinellia A, Nieric P, Saccomannia G (2000) Synthesis and b-blocking activity of (R, S)-(E)-oximeethers of 2,3-dihydro-1,8-naphthyridine and 2,3-dihydrothiopyrano[2,3-b]pyridine: Potential antihypertensive agents-Part IX. Eur J Med Chem 35:815-826
9. Hanneke MB, Marco M, Josemir WS (2008) The global burden and stigma of epilepsy. Epilepsy Behav 12:540-546
10. Huseyin U, Kim VD, Silvia C, Santi S, James PS, Paul D et al (1998) Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives. J Med Chem 41: 1138-1145
11. Inguva R, Ramaiah S, Nithyanantham M, Navaneetharaman A, Vedachalam G, Thomas LJ (2003) Pharmacological evaluation of some new 6-amino/methyl pyridine derivatives. Chem Pharm Bull 51:162-170
12. Johnson NC, Morgan MW (2006) An unusual case of 4-aminopyridine toxicity. J Emerg Med 30:175-177
13. Kaminski K, Obniska J, Zagorska A, Maciag D (2006) Synthesis, physicochemical and anticonvulsant properties of new N-(Pyridine-2-yl) derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1, 3-dione Part II. Arch Pharm 339:255-261 (Pubitemid 43798341)
14. Karthikeyan MS, Prasad DJ, Poojary B, Bhat KS, Hollaa BS, Kumarib NS (2006) Synthesis and biological activity of schiff and mannich bases bearing 2, 4-dichloro-5-fluorophenyl moiety. Bioorg Med Chem 147:7482-7489 (Pubitemid 44486797)
15. Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA (1978) Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 19:409-428 (Pubitemid 9016848)
16. Krishnan A, Ritvik, Chowdhury D (2007) Cost of antiepileptic drugs in India. Neurol Asia 12:42-43
17. Kupferberg HJ (1989) Antiepileptic drug development program: A cooperative effort of government and industry. Epilepsia 30:51-56
18. Litchfield JT, Wilcoxon FA (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99-133
19. Löscher W, Fassbender CP, Nolting B (1991) The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 8:79-94
20. Ludden CT, Scriabine A, Ulm EH, Morgan G, Fisher MH, Ruyle WV (1979) Antihypertensive activity of some novel pyridinylidene arylurea derivatives in spontaneously hypertensive rats. Experientia 15:799-801 (Pubitemid 9196334)
21. Narendar P, Parthiban J, Anbalagan N, Gunasekaran V, Leonard JT (2003) Pharmacological evaluation of some new 2-substituted pyridine derivatives. Biol Pharm Bull 26:182-187 (Pubitemid 41699662)
22. Noviasky JA, Porsteinsson AP, Lee YH (2001) Second generation anticonvulsant medications: Their use in children. J Sch Nurs 17:103-111
23. Pandey S, Srivastava RS (2009) Anticonvulsant activity of some schiff bases synthesized from 2-aminopyridine. Pharmacologyonline 2:1048-1074
24. Pandeya SN, Sriram D, Nath G, DeClercq E (1999) Synthesis, antibacterial, antifungal and anti-HIV activities of schiff and mannich bases derived from isatin derivatives and N-[4-(4'-chlorophenyl)thiazol-2-yl]thiosemicarbazide. Eur J Pharm Sci 9:25-31 (Pubitemid 29430189)
25. Pandeya SN, Yogeeswari P, Stables JP (2000) Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones. Eur J Med Chem 35:879-886
26. Pankaja KK (1991) University of Kentucky Research Foundation, US patent 5648369
27. Pickett TA, Enns R (1996) A typical presentation of 4-aminopyridine overdose. Ann Emerg Med 27:382-385
28. Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B, White BG (1984) Antiepileptic drug development program. Cleve Clin Q 51:293-305 (Pubitemid 14038030)
29. Swinyard EA (1969) Laboratory evaluation of antiepileptic drugs. Epilepsia 10:107-119
30. World Health Organization (2001) International classification of functioning disability and health: ICF, Geneva